Differentiated Thyroid Cancer Long-Term Outcomes and Risk Stratification in Pediatric and Adolescent Patients: A 44-Year Retrospective Study
Background: Differentiated thyroid cancer (DTC) in children and adolescents is a rare but significant malignancy, often presenting at more advanced stages compared to adults, although it is associated with favorable long-term outcomes. This study aimed to identify prognostic factors and perform risk stratification with the goal of identifying low-risk patients who would benefit from a less radical treatment approach. Methods: This retrospective cohort study included patients aged 21 years and younger with DTC treated at the Institute for Oncology and Radiology of Serbia between 1980 and 2024. Results: The study analyzed 99 patients (39 children, 60 adolescents) with a median follow-up of 15.6 years (range: 0.6–43.6 years). No significant differences in long-term outcomes were observed between children and adolescents. Multivariate regression analysis identified a total number of more than 10.5 positive lymph nodes and extrathyroidal tumor extension as independent predictors of adverse events and event-free interval (EFI). Using these prognostic factors, patients were stratified into three groups: low-risk (no risk factors), intermediate-risk (one of two risk factors), and high-risk (both risk factors). Statistically significant differences in EFI were observed among the three groups. Notably, none of the patients in the low-risk group had evidence of disease after treatment. Patients classified as having no evidence of disease after treatment demonstrated significantly better EFI compared to those with evidence of disease. Conclusions: Our findings highlight the importance of meticulous risk stratification in predicting long-term outcomes and might serve as a basis for developing personalized therapeutic strategies. Identifying low-risk patients who may benefit from a less aggressive treatment approach while ensuring optimal treatment and follow-up for high-risk patients remains a central objective in the modern management of DTC.
Authors
- Nevena Savkovic
- Dušica Gavrilović (ORCID: https://orcid.org/0000-0002-2368-683X)
- Nikola Jeftić (ORCID: https://orcid.org/0000-0002-5768-6256)
- Ana Jotić (ORCID: https://orcid.org/0000-0001-9862-592X)
- Merima Goran (ORCID: https://orcid.org/0000-0001-5756-1587)
- Marko Buta (ORCID: https://orcid.org/0000-0001-8062-1250)
- Nada Santrač (ORCID: https://orcid.org/0000-0001-7179-5435)
- Milan Žegarac (ORCID: https://orcid.org/0000-0002-3917-541X)
- Neven Jokic
- Ana Cvetković (ORCID: https://orcid.org/0000-0001-5933-9453)
- Ivan Marković (ORCID: https://orcid.org/0000-0003-2706-1607)
- Jovan Raketic (ORCID: https://orcid.org/0009-0004-7105-9883)
- Marko Stojanović (ORCID: https://orcid.org/0000-0002-6606-7449)
- S. Pavlovic
Institutions
- University of Belgrade (RS)
- Oncology Institute of Vojvodina (RS)
Publication Details
- Journal
- Diagnostics
- Published
- 2025-02-07
- DOI
- https://doi.org/10.3390/diagnostics15040399
- Citations
- 1
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.29